MAPT and Alzheimer disease: Considerable progress has been made in improvingour understandingof the molecular pathophysiology of AD/ADRD and has led to substantialinvestments in therapeutics and diagnostics based on markers suchas amyloid-β (Aβ) and the major microtubule-associatedprotein tau.